The National Institute of Standards & Technology (NIST) SBIR solicitation, originally scheduled for October 2013, was finally released February 19, 2014 with a closing date of May 2, 2014.Continue reading
Author Archive: AZBio
UA Study Changes Several Beliefs About the Immune System in Aging Adults
Results may help scientists understand which older adults may have impaired immune systems, allowing early intervention to improve protection against infectious diseases, which remain a prominent killer in those over age 65.Continue reading
UA Undergrad’s Research Involves Plant With Anti-Tumor Potential
Philipp von Bieberstein’s research focuses on the plant Withania somnifera, a member of the tomato family that contains a potential anti-tumor agent.
New Survey Reveals Real World Impact of Medical Device Tax
Results Show Substantial Job Loss, Reduction in R&DContinue reading
Industry leaders reach out to CMS on proposed changes to Medicare Part D
Organizations reflecting a wide breadth of companies and organizations representing, among others, multiple healthcare sectors, employers and patients share concerns over the proposed Medicare Part D changes with CMS Administrator.Continue reading
UA Study on Flu Evolution May Change Textbooks, History Books
A new study reconstructing the evolutionary tree of flu viruses challenges conventional wisdom and solves some of the mysteries surrounding flu outbreaks of historical significance
Of mice and men: fine-tuning salmonella-based vaccines
An innovative vaccine technology makes use of reengineered salmonella to deliver protective immunity. If such recombinant attenuated salmonella vaccines, or RASVs, can be perfected, they hold the promise of safe, low-cost, orally-administered defenses against viral, bacterial, fungal and parasitic infections.Continue reading
UA scientist pushes new uses for DNA tests
Frederick Zenhausern, a former nanobioscience researcher at the University of Arizona, is starting a company to develop a DNA test to catch criminals.
TGen Physician-In-Chief Dr. Daniel Von Hoff inducted today into exclusive Joshua Lederberg Society
Dr. Von Hoff is honored for advancing FDA approved treatment benefiting pancreatic cancer patientsContinue reading
Tucson To Host Globally Recognized Cancer Research Conference Feb. 25 And 26
The world’s top scientific minds will convene at Tucson’s Hilton El Conquistador Resort February 25 and 26 to collaborate and share leading-edge developments in cancer diagnostics and treatment. The 10th Annual Tucson Symposium puts Tucson at the leading edge of cancer research, diagnostics and treatment, and promises to further the field of personalized medicine and positively impact medical practice all over the world. (PR Newswire: TUCSON, Ariz., Feb. 13, 2014 )Continue reading